Wearable Injectors Market Scope And Analysis

Report Code : TIPMD00002677
Category : Life Sciences

No. of Pages : 150

Buy Now

Wearable Injectors Market Scope and Analysis Report by 2031

Buy Now

Wearable Injectors Market Report Scope

Report Attribute	Details
Market size in 2023	US$ 8.98 Billion
Market Size by 2031	US$ 21.61 Billion
Global CAGR (2023 - 2031)	11.6%
Historical Data	2021-2022
Forecast period	2024-2031
Segments Covered	By Type On-Body Injectors Off-Body Injectors By Application Diabetes Oncology Cardiovascular Disease Autoimmune Disease Other Applications By End User Hospitals and Clinics Homecare Settings Other End Users
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Amgen Inc Medtronic BD Insulet Corporation Gerresheimer AG Sensile Medical West Pharmaceutical Services Inc Ypsomed AG Tandem Diabetes Care Inc CeQur SA Debiotech S A

Wearable Injectors Market News and Recent Developments

The wearable injectors market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for wearable injectors and strategies:

Ypsomed enters a partnership with ten23 health, a global Swiss contract development and manufacturing organization. The aim of this collaboration is to advance the commercialization of the YpsoDose wearable injector for the subcutaneous self-injection of large-volume doses. ten23’s drug development, filling and device assembly expertise will significantly contribute to the product offering. (Source: Ypsomed Company Name, Press Release, 2024)
Eitan Medical, a global leader in advanced infusion therapy and drug delivery solutions with reliable innovations that put patients at the center of care, is pleased to announce the successful completion of sale and transition of its wearable injectors business to LTS, a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems. The strategic acquisition marks a milestone for both organizations and sets the stage for further advancements in the field of patient-centric drug delivery systems. (Source: Eitan Medical Company Name, Newsletter, 2023)

Wearable Injectors Market Report Coverage and Deliverables

The “Wearable Injectors Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Market dynamics such as drivers, restraints, and key opportunities
Key future trends
Detailed PEST/Porter’s Five Forces and SWOT analysis
Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
Detailed company profiles